brain tumors

The hybrid retreat showcased the latest gastric cancer, blood cancer, pediatric sarcoma, glioblastoma, breast cancer, and immune micro-environment research.

DCI member H. Kim Lyerly, MD, and pediatric neuro-oncologist Daniel Landi, MD, are co-leaders on the new cross-institutional project.

Duke Neurosurgery researchers have identified a driver of resistance to immunotherapies in deadly brain tumors, which could be targeted — allowing this type of drug to do its work. 

Zach Reitman, MD, PhD, was awarded an NCI Mentored Clinical Scientist Research CDA for research into targeted radiation therapy in pediatric brainstem tumors.

Kristen Batich, MD, PhD, a Duke Neurosurgery postdoctoral fellow in the Sampson Lab, will research anti-tumor immunity in brain tumors.

The Preston Robert Tisch Brain Tumor Center kicked off Brain Tumor Awareness Month (May) on April 30 with their first full-scale Angels Among Us event since the pandemic began.

The Preston Robert Tisch Brain Tumor Center is holds its 29^th annual Angels Among Us 5K and Walk of Hope on Saturday, April 30. Join us!

Nine-year brain cancer survivor Shelby Black talks about her experiences with Bobby's Coaches, Duke's peer support program for young adults with cancer.

Gerald Grant, MD, returns to Duke from Stanford University, where he's an endowed professor and chief of Pediatric Neurosurgery.

Stacia Smart rolled in to Duke Medicine Circle on Oct. 8 to welcoming cheers. She had just cycled 1,100-mile in memory of her boyfriend Owen Strong who passed away from glioblastoma in Jan. 2020.

The V Foundation's Victory Ride to Cure Cancer was back as a LIVE cycling event and celebration, Aug. 28. Team DCI "virtual" and in-person riders raised more than $20K.

Hai Yan, MD, PhD, was awarded the International Prize for Translational Neuroscience for identifying genetic mutations linked to gliomas.

McKinnon Bowen picked up running after his brain cancer diagnosis. Now he's using his new talent to support those who healed him.

Beloved Duke Cancer Institute member Dina Randazzo, DO, assistant professor of Neurosurgery and Neurology, has passed away.

The finding from a genetic analysis of tumors treated with Duke’s poliovirus therapy suggests a predictive biomarker for survival.

The Angels Among Us 5K & Walk of Hope will now run virtually from Sept. 25 through Oct. 10. Run, walk, bike, or crawl a 5K and/or 1-miler. Join an online Celebration of Hope.

After losing her younger brother to cancer, Ross Harris says getting involved with Duke Cancer Institute gave her power over the disease.

After losing their "brain sister," three "brain brothers" carry on her message of hope in the fight against brain cancer.

The authors, including corresponding author Madan Kwatra, MD, report that osimertinib inhibits the constitutive activity of EGFRv III tyrosine kinase with high potency.

"It's my comfort spot. I can live my life when I’m here, even if I’m not feeling well, and they are always here to take care of me.”

Genetic testing at Duke revealed a devastating diagnosis for a young nurse. But she feels it also may have saved her life.

DCI researchers use the modified polio virus to spur natural immune attack against tumors in animal studies.

Duke Cancer Institute hosted its Sixth Annual Scientific Retreat on Friday, October 25; attracting 166 DCI physicians, researchers, staff, and guests.

As recently as ten years ago, patients with brain metastasis were rarely offered surgical treatment.It was essentially viewed as a death sentence.